Cited by 1,056COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Dermatological and COVID-19 studies

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

Open access
Mao, Ren, Qiu, Yun, He, Jin-Shen, Tan, Jin-Yu, Li, Xue-Hua, Liang, Jie, Shen, Jun, Zhu, Liang-Ru +5 more·2020·The Lancet Gastroenterology & Hepatology

Abstract

Background The prevalence and prognosis of digestive system involvement, including gastrointestinal symptoms and liver injury, in patients with COVID-19 remains largely unknown. We aimed to quantify the effects of COVID-19 on the digestive system.Methods In this systematic review and meta-analysis, we systematically searched PubMed, Embase, and Web of Science for studies published between Jan 1, 2020, and April 4, 2020. The websites of WHO, CDC, and major journals were also searched. We included studies that reported the epidemiological and clinical features of COVID-19 and the prevalence of gastrointestinal findings in infected patients, and excluded preprints, duplicate publications, reviews, editorials, single case reports, studies pertaining to other coronavirus-related illnesses, and small case series (<10 cases). Extracted data included author; date; study design; country; patient demographics; number of participants in severe and non-severe disease groups; prevalence of clinical gastrointestinal symptoms such as vomiting, nausea, diarrhoea, loss of appetite, abdominal pain, and belching; and digestive system comorbidities including liver disease and gastrointestinal diseases. Raw data from studies were pooled to determine effect estimates.Findings We analysed findings from 35 studies, including 6686 patients with COVID-19, that met inclusion criteria. 29 studies (n=6064) reported gastrointestinal symptoms in patients with COVID-19 at diagnosis, and the pooled prevalence of digestive system comorbidities was 4% (95% CI 2-5; range 0-15; I 2=74%). The pooled prevalence of digestive symptoms was 15% (10-21; range: 2-57; I 2=96%) with nausea or vomiting, diarrhoea, and loss of appetite being the three most common symptoms. The pooled prevalence of abnormal liver functions (12 studies, n=1267) was 19% (9-32; range 1-53; I 2=96%). Subgroup analysis showed patients with severe COVID-19 had higher rates of abdominal pain (odds ratio [OR] 7·10 [95% CI 1·93-26·07]; p=0·003; I 2=0%) and abnormal liver function including increased ALT (1·89 [1·30-2·76]; p=0·0009; I 2=10%) and increased AST (3·08 [2·14-4·42]; p<0·00001; I 2=0%) compared with those with non-severe disease. Patients in Hubei province, where the initial COVID-19 outbreak occurred, were more likely to present with abnormal liver functions (p<0·0001) compared with those outside of Hubei. Paediatric patients with COVID-19 had a similar prevalence of gastrointestinal symptoms to those of adult patients. 10% (95% CI 4-19; range 3-23; I 2=97%) of patients presented with gastrointestinal symptoms alone without respiratory features. Patients who presented with gastrointestinal system involvement had delayed diagnosis (standardised mean difference 2·85 [95% CI 0·22-5·48]; p=0·030; I 2=73%). Patients with gastrointestinal involvement tended to have a poorer disease course (eg, acute respiratory distress syndrome OR 2·96 [95% CI 1·17-7·48]; p=0·02; I 2=0%).Interpretation Our study showed that digestive symptoms and liver injury are not uncommon in patients with COVID-19. Increased attention should be paid to the care of this unique group of patients.Funding None.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(20)30126-6

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [52]Jin X Lian J Hu J Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Gut 2020 published online March 24. 10.1136/gutjnl-2020-320926 PMC7133387 32213556 · DOI

Cited by

Sorted by citations

Authors
Mao, R., Qiu, Y., He, J.-S., Tan, J.-Y., Li, X.-H., Liang, J., Shen, J., Zhu, L.-R., Chen, Y., Iacucci, M., Ng, S. C., Ghosh, S., & Chen, M.-H.
Affiliations
  • The First Affiliated Hospital, Sun Yat-sen University (CN)
  • National Clinical Research Center for Digestive Diseases (CN)
  • Shanghai Jiao Tong University (CN)
  • Wuhan Union Hospital (CN)
  • Second Affiliated Hospital of Zhejiang University (CN)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Chinese University of Hong Kong (HK)
Corresponding author
Mao, Ren
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2020-07
Volume
5
Issue
7
Pages
667-678
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3025587545
Cited by
1,056
References
72
Citations by year
2026: 16 · 2025: 29 · 2024: 75 · 2023: 146 · 2022: 277 · 2021: 317 · 2020: 195
FWCI
11.05
Type
journal article
Language
en
Open access
Locations
  • The Lancet. Gastroenterology & hepatology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
Keywords
COVID-19 pandemic, gastrointestinal symptoms, liver injury, abnormal liver function, nausea and vomiting, diarrhea, abdominal pain, appetite loss, alanine aminotransferase, disease severity, prognosis, SARS-CoV-2
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Gastrointestinal Diseases, Humans, Liver Diseases, Pneumonia, Viral, Prognosis, Prevalence, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review